CVR: 27174965
ROSE PHARMA A/S was a Danish company of the type Aktieselskab based in Roskilde, founded in 2003 and dissolved in 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity amounted to DKK 979,327.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringScreen owners and management against the Danish FSA's official PEP lists
As of April 23, 2020, Steen Rode has stepped down as liquidator of ROSE PHARMA A/S.
On April 23, 2020, ROSE PHARMA A/S exited liquidation.
ROSE PHARMA A/S was dissolved on April 23, 2020.
As of September 11, 2018, Steen Rode is registered as liquidator of ROSE PHARMA A/S.
On September 11, 2018, ROSE PHARMA A/S entered liquidation.
As of August 22, 2018, Pryds Statsautoriseret Revisionsfirma has stepped down as auditor of ROSE PHARMA A/S.
As of August 22, 2018, Leif Helth Jensen has left the board of directors of ROSE PHARMA A/S.
As of August 22, 2018, Leif Helth Jensen has stepped down as adm. dir of ROSE PHARMA A/S.
As of August 22, 2018, Michael Forer has stepped down as chairman of ROSE PHARMA A/S.
ROSE PHARMA A/S has published its annual report for 2016. Gross profit came to DKK -35,218, and the net result was DKK -51,821.
ROSE PHARMA A/S has published its annual report for 2015. Gross profit came to DKK -170,730, and the net result was DKK -186,905.
ROSE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 262,551, and the net result was DKK 249,739.
As of January 7, 2015, Florian Schønharting has left the board of directors of ROSE PHARMA A/S.
ROSE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK -129,734, and the net result was DKK -133,626.
ROSE PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -335,391, and the net result was DKK -335,146.
As of June 19, 2012, Florian Schønharting has joined the board of directors of ROSE PHARMA A/S.
As of June 19, 2012, Enda Kenny has left the board of directors of ROSE PHARMA A/S.
As of June 7, 2012, Pryds Statsautoriseret Revisionsfirma has been appointed auditor of ROSE PHARMA A/S.
As of June 7, 2012, Florian Schønharting has left the board of directors of ROSE PHARMA A/S.
As of January 26, 2012, Enda Kenny has joined the board of directors of ROSE PHARMA A/S.
As of January 26, 2012, Christian Karsten Hansen has left the board of directors of ROSE PHARMA A/S.
As of January 26, 2012, Olof Gustav Paulus Isaksson has left the board of directors of ROSE PHARMA A/S.
As of January 26, 2012, Charles Woler has left the board of directors of ROSE PHARMA A/S.
As of January 26, 2012, Leif Helth Jensen is registered as adm. dir of ROSE PHARMA A/S.
As of January 26, 2012, Michael Forer is registered as chairman of ROSE PHARMA A/S.
As of January 26, 2012, Hans Thalsgård Schambye has stepped down as chairman of ROSE PHARMA A/S.
As of January 26, 2012, Enda Kenny has stepped down as adm. dir of ROSE PHARMA A/S.
As of January 3, 2012, REVISERKOMPAGNIET GODKENDTE REVISIONSINTERESSENTSKAB has stepped down as auditor of ROSE PHARMA A/S.
As of June 20, 2011, REVISERKOMPAGNIET GODKENDTE REVISIONSINTERESSENTSKAB has been appointed auditor of ROSE PHARMA A/S.
As of June 20, 2011, BASTVED CONSULTING ApS has stepped down as auditor of ROSE PHARMA A/S.
As of April 13, 2011, BASTVED CONSULTING ApS has been appointed auditor of ROSE PHARMA A/S.
As of April 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ROSE PHARMA A/S.
As of December 18, 2007, Christian Karsten Hansen has joined the board of directors of ROSE PHARMA A/S.
As of December 18, 2007, Leif Helth Jensen has joined the board of directors of ROSE PHARMA A/S.
As of December 18, 2007, Charles Woler has joined the board of directors of ROSE PHARMA A/S.
As of December 18, 2007, Lise Abildgaard Ryberg has left the board of directors of ROSE PHARMA A/S.
As of December 18, 2007, John-Olov Jansson has left the board of directors of ROSE PHARMA A/S.
As of December 18, 2007, Tamas Bartfai has left the board of directors of ROSE PHARMA A/S.
As of October 15, 2007, Enda Kenny is registered as adm. dir of ROSE PHARMA A/S.
As of October 15, 2007, Lars Folke Henrik Nilsson has stepped down as adm. dir of ROSE PHARMA A/S.
As of January 5, 2007, Jeremy Laurence Curnock Cook has left the board of directors of ROSE PHARMA A/S.
As of September 19, 2006, Olof Gustav Paulus Isaksson has joined the board of directors of ROSE PHARMA A/S.
As of September 19, 2006, Hans Thalsgård Schambye is registered as chairman of ROSE PHARMA A/S.
As of September 19, 2006, Lars Folke Henrik Nilsson is registered as adm. dir of ROSE PHARMA A/S.
As of September 19, 2006, Hans Thalsgård Schambye has stepped down as adm. dir of ROSE PHARMA A/S.
As of December 9, 2005, Jeremy Laurence Curnock Cook has joined the board of directors of ROSE PHARMA A/S.
As of August 31, 2005, Claes Tomas Post has left the board of directors of ROSE PHARMA A/S.
As of May 25, 2005, Lise Abildgaard Ryberg has joined the board of directors of ROSE PHARMA A/S.
As of April 8, 2005, Lise Abildgaard Ryberg has stepped down as direktion of ROSE PHARMA A/S.
As of February 10, 2005, Hans Thalsgård Schambye is registered as adm. dir of ROSE PHARMA A/S.
As of February 10, 2005, Claes Tomas Post has stepped down as direktion of ROSE PHARMA A/S.
As of October 4, 2004, Claes Tomas Post has joined the board of directors of ROSE PHARMA A/S.
As of October 4, 2004, Tamas Bartfai has joined the board of directors of ROSE PHARMA A/S.
As of October 4, 2004, Lise Abildgaard Ryberg is registered as direktion of ROSE PHARMA A/S.
As of March 3, 2004, Thue Walter Schwartz has left the board of directors of ROSE PHARMA A/S.
As of September 12, 2003, Claes Tomas Post is registered as direktion of ROSE PHARMA A/S.
As of September 12, 2003, Cora Louise Madsen has stepped down as direktion of ROSE PHARMA A/S.
As of September 12, 2003, Claes Tomas has stepped down as direktion of ROSE PHARMA A/S.
As of September 11, 2003, Claes Tomas is registered as direktion of ROSE PHARMA A/S.
As of June 26, 2003, Thue Walter Schwartz has joined the board of directors of ROSE PHARMA A/S.
As of May 12, 2003, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ROSE PHARMA A/S.
As of May 12, 2003, Florian Schønharting has joined the board of directors of ROSE PHARMA A/S.
As of May 12, 2003, John-Olov Jansson has joined the board of directors of ROSE PHARMA A/S.
As of May 12, 2003, Cora Louise Madsen is registered as direktion of ROSE PHARMA A/S.
ROSE PHARMA A/S was founded on May 12, 2003.
companydata.dk